ArticleCancer research and treatment2022

Comparison of the Effectiveness and Clinical Outcome of Everolimus Followed by CDK4/6 Inhibitors with the Opposite Treatment Sequence in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer.

Hyehyun Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.